Have a feature idea you'd love to see implemented? Let us know!

SLRN Acelyrin Inc

Price (delayed)

$4.33

Market cap

$434.41M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.46

Enterprise value

$224.1M

Highlights
The EPS has surged by 88% year-on-year and by 13% since the previous quarter
SLRN's net income is up by 14% year-on-year and by 12% since the previous quarter
SLRN's quick ratio is down by 43% YoY and by 13% QoQ
SLRN's equity is down by 28% year-on-year and by 7% since the previous quarter

Key stats

What are the main financial stats of SLRN
Market
Shares outstanding
100.33M
Market cap
$434.41M
Enterprise value
$224.1M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.82
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$264.41M
EBITDA
-$263.71M
Free cash flow
-$250.23M
Per share
EPS
-$2.46
Free cash flow per share
-$2.51
Book value per share
$5.29
Revenue per share
$0
TBVPS
$6.19
Balance sheet
Total assets
$618.31M
Total liabilities
$90.03M
Debt
$6.56M
Equity
$528.28M
Working capital
$513.12M
Liquidity
Debt to equity
0.01
Current ratio
7.15
Quick ratio
6.74
Net debt/EBITDA
0.8
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-39%
Return on equity
-44.1%
Return on invested capital
-66.6%
Return on capital employed
-49.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SLRN stock price

How has the Acelyrin stock price performed over time
Intraday
-2.26%
1 week
-16.09%
1 month
-29.94%
1 year
-49.77%
YTD
-41.96%
QTD
-12.17%

Financial performance

How have Acelyrin's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$335.66M
Net income
-$264.41M
Gross margin
N/A
Net margin
N/A
SLRN's net income is up by 14% year-on-year and by 12% since the previous quarter
Acelyrin's operating income has increased by 11% QoQ

Growth

What is Acelyrin's growth rate over time

Valuation

What is Acelyrin stock price valuation
P/E
N/A
P/B
0.82
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 88% year-on-year and by 13% since the previous quarter
SLRN's equity is down by 28% year-on-year and by 7% since the previous quarter
The stock's price to book (P/B) is 18% less than its last 4 quarters average of 1.0

Efficiency

How efficient is Acelyrin business performance
Acelyrin's return on invested capital has surged by 67% YoY and by 10% QoQ
Acelyrin's return on equity has surged by 54% YoY and by 4.3% QoQ
SLRN's return on assets is up by 28% year-on-year and by 6% since the previous quarter

Dividends

What is SLRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SLRN.

Financial health

How did Acelyrin financials performed over time
SLRN's quick ratio is down by 43% YoY and by 13% QoQ
The current ratio has decreased by 40% YoY and by 9% QoQ
Acelyrin's debt is 99% less than its equity
SLRN's equity is down by 28% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.